Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography

P Edison; CC Rowe; JO Rinne; S Ng; I Ahmed; N Kemppainen; VL Villemagne; G O'Keefe; K Någren; KR Chaudhury; CL Masters; DJ Brooks

Journal article

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography

P Edison, CC Rowe, JO Rinne, S Ng, I Ahmed, N Kemppainen, VL Villemagne, G O'Keefe, K Någren, KR Chaudhury, CL Masters, DJ Brooks

Journal of Neurology Neurosurgery and Psychiatry | B M J PUBLISHING GROUP | Published : 2008

DOI: 10.1136/jnnp.2007.127878

Abstract

Background: Neuropathological studies have reported varying amounts of amyloid pathology in dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD). [11C]PIB positron emission tomography (PET) is a marker of brain amyloid deposition. The aim of this study was to quantify in vivo amyloid load in DLB and PDD compared with control subjects and subjects with Parkinson's disease (PD) without dementia. Methods: 13 DLB, 12 PDD, 10 PD subjects and 41 age matched controls (55-82 years) were recruited. Each subject underwent clinical evaluation, neuropsychological assessment, T1 and T2 MRI, and [11C]PIB PET. The amyloid load was estimated from 60-90′ target regionxerebellar [11C]PIB upt..

View full abstract

University of Melbourne Researchers

Christopher Rowe Author

Victor Villemagne Author

Graeme O'Keefe Author

Grants

Awarded by Medical Research Council

Funding Acknowledgements

This study was financially supported by EVO grants from Turku University Hospital, and by grants from the Research Council for Health of the Academy of Finland (project # 205954) and the Sigrid Juselius Foundation.